Z. Zeng

发表

Comprehensive molecular characterization of human colon and rectal cancer

Steven J. M. Jones, Joshua M. Stuart, Brian D. O’Connor, 2012, Nature.

Relationship of gene expression and chromosomal abnormalities in colorectal cancer.

Eytan Domany, Francis Barany, Jinru Shia, 2006, Cancer research.

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

L. Liau, P. Mischel, I. Mellinghoff, 2013, Nature Genetics.

Logarithmic expansion of LGR5+ cells in human colorectal cancer.

E. Vakiani, Z. Zeng, M. L. Martin, 2018, Cellular signalling.

High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer.

S. Winawer, Z. Zeng, D. Klimstra, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.

C. Cordon-Cardo, J. Guillem, Z. Zeng, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High Levels of Transforming Growth Factor 1 Correlate with Disease Progression in Human Colon Cancer 1

S. Winawer, Z. Zeng, D. Klimstra, 2005 .

Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo

V. Chaudhry, J. Guillem, Z. Zeng, 1999, Clinical & Experimental Metastasis.

Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.

J. Guillem, Z. Zeng, A. Cohen, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients

Z. Zeng, A. Cohen, C. Urmacher, 1993, Diseases of the colon and rectum.

Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients.

Z. Zeng, P. Paty, M. LaQuaglia, 2016, Journal of pediatric surgery.

Colorectal Cancer The Signatures of Autozygosity among Patients with Updated

R. Stengel, D. Notterman, J. Ott, 2008 .

HER 2/neu expression and gene amplification in colon cancer

W. Gerald, F. Barany, G. Nash, 2003, International journal of cancer.

Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.

W. Stetler-Stevenson, J. Guillem, Z. Zeng, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Differential expression of protein kinase C isoforms in human colorectal cancers.

J. Guillem, Z. Zeng, H. Hug, 1995, The Journal of surgical research.

Cholecystectomy and colorectal cancer in China.

Z. Zeng, Z. F. Zhang, 1993, Surgical oncology.

Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature.

C. Sempoux, H. Al-Ahmadie, Z. Zeng, 2012, Human pathology.

Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

J. Guillem, Z. Zeng, ZS Zeng, 1995, British Journal of Cancer.

Improved Testing for Microsatellite Instability in Colorectal Cancer Using a Simplified 3-Marker Assay

L. Qin, F. Barany, G. Nash, 2010, Annals of Surgical Oncology.

Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer

W. Enker, S. Sternberg, Z. Zeng, 1992, Cancer.

Genomic and biological characterization of exon 4 KRAS mutations in human cancer.

Barry S Taylor, Marc Ladanyi, Alex Lash, 2010, Cancer research.

MDM2 Gene Amplification Is Correlated to Tumor Progression but not to the Presence of SNP309 or TP53 Mutational Status in Primary Colorectal Cancers

D. Notterman, W. Gerald, L. Qin, 2008, Molecular Cancer Research.

Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

A. Viale, Rileen Sinha, R. Shen, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer.

F. Barany, G. Nash, P. Paty, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation

M. Weiser, Z. Zeng, T. K. Chiu, 2016, Oncotarget.

KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases

N. Kemeny, G. Nash, Z. Zeng, 2010, Annals of Surgical Oncology.

Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer

F. Barany, K. Offit, Z. Zeng, 2008, Journal of surgical oncology.

Extracellular Metabolic Energetics Can Promote Cancer Progression

S. Tavazoie, Z. Zeng, L. Saltz, 2015, Cell.

c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

F. Barany, G. Nash, M. Weiser, 2008, Cancer letters.

The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts

Jinru Shia, Michael Fara, M. Weiser, 2015, Journal of Translational Medicine.

Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer

M. Weiser, Z. Zeng, P. Paty, 2005, Clinical & Experimental Metastasis.

HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells

N. Rosen, D. Solit, J. Christensen, 2008, Molecular Cancer Therapeutics.

EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer

Z. Zeng, P. Paty, S. Khan, 2017, Pathology & Oncology Research.

Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.

M. Weiser, Z. Zeng, P. Paty, 2007, Cancer letters.

The signatures of autozygosity among patients with colorectal cancer.

Jurg Ott, Kenneth Offit, Francis Barany, 2008, Cancer research.

PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.

S. Tavazoie, Z. Zeng, Y. Janjigian, 2016, The Journal of clinical investigation.

Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET-Amplified Tumor Cells with or without Resistance to Selective MET Inhibition

A. Olshen, A. Viale, N. Rosen, 2011, Clinical Cancer Research.

KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer

J. Ott, F. Barany, G. Nash, 2010, Annals of Surgical Oncology.

Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer

C. Brennan, F. Barany, Z. Zeng, 2010, International journal of cancer.

High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.

W. Enker, J. Guillem, Z. Zeng, 1994, British Journal of Cancer.

High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stage

D. Notterman, F. Barany, Z. Zeng, 2014, Medical Oncology.

CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer

D. Notterman, J. Ott, F. Barany, 2008, Clinical Cancer Research.

Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.

J. Guillem, Z. Zeng, A. Cohen, 1999, Carcinogenesis.

Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

J. Guillem, Z. Zeng, A. Cohen, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.

J. Guillem, Z. Zeng, ZS Zeng, 1996, British Journal of Cancer.

The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts

Michael Fara, M. Weiser, Z. Zeng, 2015, Journal of Translational Medicine.

Tissue inhibitor of metalloproteinase-3 is a basement membrane-associated protein that is significantly decreased in human colorectal cancer

J. Guillem, Z. Zeng, Weiping Shu, 2001, Diseases of the colon and rectum.

Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer.

J. Guillem, Z. Zeng, ZS Zeng, 1998, British Journal of Cancer.

Distinct Levels of Radioresistance in Lgr5+ Colonic Epithelial Stem Cells versus Lgr5+ Small Intestinal Stem Cells.

Z. Zeng, M. L. Martin, P. Paty, 2017, Cancer research.

Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met–expressing tumors

M. Weiser, Z. Zeng, R. DeMatteo, 2007, Molecular Cancer Therapeutics.

DNA Mismatch Repair Deficiency in Breast Carcinoma: A Pilot Study of Triple-negative and Non–Triple-negative Tumors

L. Norton, E. Brogi, Z. Zeng, 2012, The American journal of surgical pathology.

Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer.

C. Cordon-Cardo, J. Guillem, Z. Zeng, 1995, British Journal of Cancer.

Antitumor activity of SNX-2112, a synthetic heat shock protein 90 inhibitor, in malignancies with amplification of the MET oncogene.

A. Olshen, A. Viale, N. Rosen, 2010 .